C. Kobe

Large mediastinal tumor mass as a prognostic factor in Hodgkin’s lymphoma

H. Eich, C. Kobe, J. Kříž, 2012, Strahlentherapie und Onkologie.

Role of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial

M. Dietlein, P. Borchmann, A. Engert, 2022, 60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.

Should all patients with thyroid nodules ≥ 1 cm undergo fine-needle aspiration biopsy?

W. Lehmacher, M. Hellmich, O. Schober, 2009, Nuklearmedizin.

123 I-FP-CIT SPECT imaging of the dopaminergic state Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques

L. Timmermann, D. Pedrosa, M. Dietlein, 2017 .

Recombinant human TSH versus hypo thyroidism

M. Dietlein, H. Schicha, P. Theissen, 2010, Nuklearmedizin.

BRECADD IS NON‐INFERIOR TO EBEACOPP IN PATIENTS WITH ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: EFFICACY RESULTS OF THE GHSG PHASE III HD21 TRIAL

A. Rosenwald, V. Diehl, W. Klapper, 2023, Hematological Oncology.